Hutchin Hill Capital’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-31,600
Closed -$2.05M 992
2017
Q2
$2.05M Buy
+31,600
New +$2M 0.07% 313
2016
Q1
Sell
-77,300
Closed -$4.7M 788
2015
Q4
$4.7M Buy
+77,300
New +$4.6M 0.12% 159
2015
Q3
Sell
-61,600
Closed -$3.17M 772
2015
Q2
$3.17M Sell
61,600
-58,300
-49% -$3.02M 0.08% 227
2015
Q1
$6.1M Buy
119,900
+66,400
+124% +$3.42M 0.17% 116
2014
Q4
$2.85M Sell
53,500
-32,700
-38% -$1.66M 0.1% 175
2014
Q3
$3.93M Buy
+86,200
New +$4.06M 0.15% 162
2014
Q1
Sell
-12,400
Closed -$601K 741
2013
Q4
$601K Buy
+12,400
New +$580K 0.04% 348

Other funds holding XRAY

Hutchin Hill Capital's XRAY Position: Q3 2017 in Review

Hutchin Hill Capital sold out of Dentsply Sirona (XRAY) in Q3 2017, closing a stake of 31,600 shares — an estimated $2.05M sold.

Hutchin Hill Capital first reported a position in XRAY in Q4 2013 and held it in 7 quarters. The position peaked at $6.1M in Q1 2015. 536 funds tracked by Wall St. Rank hold XRAY as of Q3 2017.

  • Hutchin Hill Capital reported no remaining Dentsply Sirona position as of Q3 2017 after selling out during the quarter.
  • Hutchin Hill Capital sold 31,600 Dentsply Sirona shares in Q3 2017, an estimated $2.05M.
  • Hutchin Hill Capital first reported a position in Dentsply Sirona in Q4 2013 and held it in 7 quarters.
  • Hutchin Hill Capital's Dentsply Sirona position peaked at $6.1M in Q1 2015.
  • 536 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2017.

Based on Hutchin Hill Capital's 13F filing for Q3 2017, filed 14 Nov 2017.